Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

On 20/03/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 443. The active ingredient is Elafin for treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.